http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2530625-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5f554278206e52fc0b4acdf30628464 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_175f64d45b89d2c83c03545548deeff9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e840fd19a7ecf7418b9dd92f0641fbf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fef521bbb6715a128d74589fb6ba5c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_550bc79f65c062570fdbc074d114af5e |
| publicationDate | 2014-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2530625-C2 |
| titleOfInvention | Method of treating pemphigus vulgaris |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, specifically dermatology, and can be used for treating patients with pemphigus vulgaris. That is ensured by prescribing prednisolone in a dose of 1 mg/kg/day for 7 days. On the 7 th day, Metoject is administered subcutaneously in a dose of 7.5 mg once a day for 3-4 weeks. On the following day of the above administration, the dose of prednisolone is reduced by 1/3, after the following injections, the dose of prednisolone is reduced by 5-10 mg after each following injection. n EFFECT: invention enables providing higher clinical effectiveness in the patients with pemphigus vulgaris with a lower risk of complications. n 2 ex, 2 tbl |
| priorityDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.